2007
DOI: 10.1152/physiolgenomics.00194.2006
|View full text |Cite
|
Sign up to set email alerts
|

A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human

Abstract: Type 2 diabetes mellitus is the result of a combination of impaired insulin secretion with reduced insulin sensitivity of target tissues. There are an estimated 150 million affected individuals worldwide, of whom a large proportion remains undiagnosed because of a lack of specific symptoms early in this disorder and inadequate diagnostics. In this study, NMR-based metabolomic analysis in conjunction with multivariate statistics was applied to examine the urinary metabolic changes in two rodent models of type 2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

46
356
2

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 375 publications
(404 citation statements)
references
References 48 publications
46
356
2
Order By: Relevance
“…Although this model has shortcomings (Breyer et al 2005;Brosius et al 2009;Breyer 2012), these mice do recapitulate early renal consequences of systemic hyperglycemia, such as the development of glomerular hyperfiltration (elevated glomerular filtration rate (GFR) above the normal filtration rates), increased albuminuria and some histopathologic changes. Metabolomic comparisons of urinary metabolites show similarities between this mouse model and type 2 diabetic humans (Salek et al 2007). Similar to many cases of human type 2 diabetes mellitus, obesity drives this disease in db/db mice.…”
mentioning
confidence: 75%
“…Although this model has shortcomings (Breyer et al 2005;Brosius et al 2009;Breyer 2012), these mice do recapitulate early renal consequences of systemic hyperglycemia, such as the development of glomerular hyperfiltration (elevated glomerular filtration rate (GFR) above the normal filtration rates), increased albuminuria and some histopathologic changes. Metabolomic comparisons of urinary metabolites show similarities between this mouse model and type 2 diabetic humans (Salek et al 2007). Similar to many cases of human type 2 diabetes mellitus, obesity drives this disease in db/db mice.…”
mentioning
confidence: 75%
“…15 Urinary levels of hippurate have been shown to correlate with the obese phenotype in different animal models [16][17][18][19] and to associate with the fecal counting of several bacterial species in a rat model of obesity; 16 moreover, lower levels of hippurate were found in the urinary metabolic phenotypes of human type-2 diabetes mellitus patients. 17 Hippurate has also been inversely linked to blood pressure, suggesting a further connection with diet and obesity. 20 The changes in urinary excretion of trigonelline (N-methylnicotinate) indicate a class-specific metabolism of niacin, which is an essential vitamin involved in major Gut flora and human obese metabotype R Calvani et al physiological functions such as a coenzyme in tissue respiration, and carbohydrate and lipid metabolism.…”
Section: Resultsmentioning
confidence: 99%
“…10 Metabolomics is a rapidly advancing field that aims to characterize the concentration changes of all small molecules existing in a biofluid.11 Application of metabolomic technologies to the understanding of physiology, toxicology, and disease progression has led to appreciable advances by defining novel drug and carcinogen metabolites,12-15 as well as biomarkers of disease. 16,17 At the same time, the metabolomic technologies have contributed to a general understanding of how metabolites and their concentrations change under defined conditions.18 However, in contrast to transcriptomics and proteomics, broadbased metabolomic studies have not been used to analyze the cellular effects of IR. Smallscale, directed approaches using high-sensitivity nuclear magnetic resonance spectroscopy (NMR) [19][20][21][22][23] have been applied to estimate the relative concentration changes of a small subset of metabolites (e.g., reduced glutathione) following IR, but a global metabolomic approach has not yet been reported.…”
mentioning
confidence: 99%